Aptar Pharma Bolsters Clinical Trial Capabilities with Strategic Materials Manufacturing Acquisition
Go back to Aptar Pharma Bolsters Clinical Trial Capabilities with Strategic Materials Manufacturing Acquisition| APTARGROUP, Inc. (NYSE: ATR) | Delayed: 124.84 +1.79 (1.45%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $123.05 | 52 Week High | $81.50 | |||
| Open | $124.85 | 52 Week Low | $66.33 | |||
| Day High | $125.60 | P/E | 49.54 | |||
| Day Low | $123.06 | EPS | $2.52 | |||
| Volume | 491,920 | |||||
